EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine the effects of pagoclone on the symptoms of
Persistent Developmental Stuttering, using a flexible dosing titration regimen on persistent
developmental stuttering in patients 18 to 65 years of age.